Efficacy of the anti-seizure medications in acute symptomatic neonatal seizures caused by stroke. A systematic review
- PMID: 36533757
- PMCID: PMC9828920
- DOI: 10.23750/abm.v93i6.13440
Efficacy of the anti-seizure medications in acute symptomatic neonatal seizures caused by stroke. A systematic review
Abstract
Background and aim: Neonatal stroke is the second cause of acute symptomatic neonatal seizures after hypoxic-ischemic encephalopathy. The aim of this systematic review is to determine which drug among those available represents the best therapeutic choice for treatment of secondary seizures due to neonatal stroke.
Methods: We performed a systematic review searching on PubMed the keywords "Neonatal", "Stroke", "Seizures" and "Treatment". Search was limited only to English language with no time limit. Last literature search was done on May 30, 2022.
Results: We selected 5 articles involving a total of 52 full-term neonates. In 96.1% the first line treatment was phenobarbital and in 3.9% was used phenobarbital associated with midazolam from the seizure onset but in all of these cases it was necessary to introduce further medications for controlling the seizures. As second line treatment was used lidocaine (response rate of 53.3%), midazolam (response rate of 15.38%) bumetanide (response rate of 100%), and fosphenytoin (no response). As third line treatment was used lidocaine (response rate of 87.5%), Midazolam (response rate of 60%), levetiracetam and clonazepam (response rate of 100%).
Conclusions: Our review shows that the use of ASMs that act throughout a gabaergic mechanism are inadequate in controlling seizures secondary to neonatal stroke in full-term newborns. Very effective seems to be lidocaine and levetiracetam with an apparent safer profile in short and long term. Bumetanide shows promising results, but they need to be confirmed by phase 3 studies.
Conflict of interest statement
Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.
Figures
Similar articles
-
The use of phenobarbital and other anti-seizure drugs in newborns.Semin Fetal Neonatal Med. 2017 Oct;22(5):321-327. doi: 10.1016/j.siny.2017.07.008. Epub 2017 Aug 12. Semin Fetal Neonatal Med. 2017. PMID: 28811085 Review.
-
Bumetanide potentiates the anti-seizure and disease-modifying effects of midazolam in a noninvasive rat model of term birth asphyxia.Epilepsy Behav. 2023 May;142:109189. doi: 10.1016/j.yebeh.2023.109189. Epub 2023 Apr 8. Epilepsy Behav. 2023. PMID: 37037061
-
Efficacy of Levetiracetam as Add-On Therapy in the Treatment of Seizures in Neonates.Neonatology. 2024;121(2):233-243. doi: 10.1159/000535499. Epub 2023 Dec 19. Neonatology. 2024. PMID: 38113859 Free PMC article.
-
Treatment of seizures in the neonate: Guidelines and consensus-based recommendations-Special report from the ILAE Task Force on Neonatal Seizures.Epilepsia. 2023 Oct;64(10):2550-2570. doi: 10.1111/epi.17745. Epub 2023 Sep 1. Epilepsia. 2023. PMID: 37655702
-
Lidocaine response rate in aEEG-confirmed neonatal seizures: Retrospective study of 413 full-term and preterm infants.Epilepsia. 2016 Feb;57(2):233-42. doi: 10.1111/epi.13286. Epub 2015 Dec 31. Epilepsia. 2016. PMID: 26719344
Cited by
-
Anti-seizure medications for neonates with seizures.Cochrane Database Syst Rev. 2023 Oct 24;10(10):CD014967. doi: 10.1002/14651858.CD014967.pub2. Cochrane Database Syst Rev. 2023. PMID: 37873971 Free PMC article.
-
Hemorrhagic stroke in children.J Cent Nerv Syst Dis. 2024 Nov 1;16:11795735241289913. doi: 10.1177/11795735241289913. eCollection 2024. J Cent Nerv Syst Dis. 2024. PMID: 39493255 Free PMC article. Review.
References
-
- Bernson-Leung ME, Rivkin MJ. Stroke in neonates and children. Pediatr Rev. 2016;37:463–477. - PubMed
-
- Dunbar M, Kirton A. Perinatal stroke: mechanisms, management, and outcomes of early cerebrovascular brain injury. Lancet Child Adolesc Health. 2018 Sep;2(9):666–67. - PubMed
-
- Morin L, Enderlin J, Leger PL. Different response to antiepileptic drugs according to the type of epileptic events in a neonatal ischemia-reperfusion model. Neurobiol Dis. 2017 Mar;99:145–153. - PubMed
-
- Nardou R, Ferrari DC, Ben-Ari Y. Mechanisms and effects of seizures in the immature brain. Semin Fetal Neonatal Med. 2013 Aug;18(4):175–84. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials